Veradigm Inc.
MDRX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.16 | -233.68 | -0.01 | 58.51 |
| FCF Yield | 3.66% | -0.00% | -5.38% | -0.01% |
| EV / EBITDA | 35.03 | 9,865.32 | 18.83 | 152,978.19 |
| Quality | ||||
| ROIC | -0.66% | 3.16% | -2.55% | -3.54% |
| Gross Margin | 52.45% | 44.71% | 37.65% | 35.19% |
| Cash Conversion Ratio | – | -0.56 | -0.15 | -0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -26.86% | -29.28% | -4.95% | 2.92% |
| Free Cash Flow Growth | 206.10% | 36.55% | -46.96% | -27.75% |
| Safety | ||||
| Net Debt / EBITDA | -3.89 | 0.76 | -2.27 | 84.47 |
| Interest Coverage | -4.27 | 5.73 | -1.68 | -2.31 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 68.81 | 278.56 | 102.48 | 80.27 |